Financhill
Back

Immunovant 10K Form

Sell
40

IMVT
Immunovant

Last Price:
29.38
Seasonality Move:
5.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IMVT News And Ratings

See the #1 stock for the next 7 days that we like better than IMVT

IMVT Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-47.23M
Price / Cash Flow: 0
Annual Sales: $4.68
Price / Book: 6.57

Profitability

EPS (TTM): -1.84000
Net Income (TTM): $-243.45M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Immunovant Earnings Forecast

Key Immunovant Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 4 years have been positive in 1 years.

Immunovant Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Current Symbol: IMVT
CUSIP: 45258J
Website: immunovant.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IMVT Technical Analysis vs Fundamental Analysis

Sell
40
Immunovant (IMVT) is a Sell

Is Immunovant a Buy or a Sell?

  • Immunovant stock is rated a Sell
    The current Immunovant [IMVT] share price is $30.71. The Score for IMVT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.